PALIPERIDONE
- Product NDC
- 72658-1256
- 11-digit product format
- 726581256
- Labeler code
- 72658
- Product ID
- 72658-1256_3e4a14d9-8d90-5f05-e063-6294a90a110e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PALIPERIDONE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Eskayef Pharmaceuticals Limited
- Application
- ANDA218755
- Marketing category
- ANDA
- Marketing start
- 2025-10-02
- Substance
- PALIPERIDONE
- Active strength
- 9 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218755-001 | PALIPERIDONE | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | |
| A218755-002 | PALIPERIDONE | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | |
| A218755-003 | PALIPERIDONE | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | |
| A218755-004 | PALIPERIDONE | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218755-001 | AB |
| A218755-002 | AB |
| A218755-003 | AB |
| A218755-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218755-001 | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-002 | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-003 | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-004 | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-001 | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-002 | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-003 | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-004 | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-001 | PALIPERIDONE | 1.5MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-002 | PALIPERIDONE | 3MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-003 | PALIPERIDONE | 6MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-004 | PALIPERIDONE | 9MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2025-09-04 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218755-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A218755-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218755-004 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218755-004 | AB | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PALIPERIDONE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PALIPERIDONE | 9 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 838F01T721 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| de95e29f-a030-4777-a601-874500ab8e91 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3752075e-d817-45ea-9aa1-8dc0301cf2aa | Product name | 1 | 20251114 |
| 893dce58-6330-4a9a-ab03-5ffd7148e184 | Product name | 1 | 20250311 |
| b6847380-b533-d626-e29e-10b60b2ad451 | Product name | 9 | 20250303 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| fd328049-536a-4914-b42e-93bf4d93db24 | Product name | 1 | 20220307 |
| 0f0756fc-4d63-4f75-afcc-9c5e62a38d69 | Product name | 2 | 20220304 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72658-1256-1 | PALIPERIDONE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 1 | |
| 72658-1256-2 | PALIPERIDONE | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 1 | |
| 72658-1256-3 | PALIPERIDONE | 500 in 1 PACKAGE | TABLET, EXTENDED RELEASE | 500 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | ff5ef11c-5c22-4a8e-89dd-4740f0ebf634 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | f75e884e-1883-45d7-ac9b-4a6c63f2185e | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | f0c13f91-0232-48b0-aa13-121805b8da13 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Bryant Ranch Prepack | c7472b50-fa6c-4127-a4b3-3645436274ee | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| Paliperidone | PALIPERIDONE | Westminster Pharmaceuticals, LLC | 1745a460-5e3a-4a1f-8eb3-64bb112f47a4 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 |
| PALIPERIDONE | PALIPERIDONE | Eskayef Pharmaceuticals Limited | de95e29f-a030-4777-a601-874500ab8e91 | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | 218755 ANDA218755 72658-1256 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 866103 | paliperidone 1.5 MG 24HR Extended Release Oral Tablet | PSN | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672567 | paliperidone 3 MG 24HR Extended Release Oral Tablet | PSN | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672569 | paliperidone 6 MG 24HR Extended Release Oral Tablet | PSN | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672571 | paliperidone 9 MG 24HR Extended Release Oral Tablet | PSN | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 866103 | 24 HR paliperidone 1.5 MG Extended Release Oral Tablet | SCD | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672567 | 24 HR paliperidone 3 MG Extended Release Oral Tablet | SCD | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672569 | 24 HR paliperidone 6 MG Extended Release Oral Tablet | SCD | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672571 | 24 HR paliperidone 9 MG Extended Release Oral Tablet | SCD | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 866103 | paliperidone 1.5 MG 24 HR Extended Release Oral Tablet | SY | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672567 | paliperidone 3 MG 24 HR Extended Release Oral Tablet | SY | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672569 | paliperidone 6 MG 24 HR Extended Release Oral Tablet | SY | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
| 672571 | paliperidone 9 MG 24 HR Extended Release Oral Tablet | SY | de95e29f-a030-4777-a601-874500ab8e91 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 72658-1256-1 | 72658125601 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1256-1) | 2025-10-02 | No | No | Current |
| 72658-1256-2 | 72658125602 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1256-2) | 2025-10-02 | No | No | Current |
| 72658-1256-3 | 72658125603 | 500 TABLET, EXTENDED RELEASE in 1 PACKAGE (72658-1256-3) | 2025-10-02 | No | No | Current |